 | • レポートコード：GIR-2104Z07271 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ハンチントン病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ハンチントン病治療の種類別市場規模（対症療法、疾患修飾療法）、用途別市場規模（病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ハンチントン病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bausch Health、Teva Pharmaceuticals、Wave Life Sciences、Ionis Pharmaceuticals/ Roche、Raptor Pharmaceuticals、Prana Biotechnology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：対症療法、疾患修飾療法 ・用途別分析2016年-2026年：病院、外来手術センター ・ハンチントン病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ハンチントン病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ハンチントン病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ハンチントン病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ハンチントン病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Huntington’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Huntington’s Disease Treatment size is estimated to be USD 509 million in 2025 from USD 180.4 million in 2019, with a change XX% between 2019 and 2020. The global Huntington’s Disease Treatment market size is expected to grow at a CAGR of 29.6% for the next five years.
Market segmentation
Huntington’s Disease Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Symptomatic Therapy
Disease-Modifying Therapy
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centers
Market segment by players, this report covers
Bausch Health
Teva Pharmaceuticals
Wave Life Sciences
Ionis Pharmaceuticals/ Roche
Raptor Pharmaceuticals
Prana Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Huntington’s Disease Treatment
1.2 Classification of Huntington’s Disease Treatment by Type
1.2.1 Overview: Global Huntington’s Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Huntington’s Disease Treatment Revenue Market Share by Type in 2020
1.2.3 Symptomatic Therapy
1.2.4 Disease-Modifying Therapy
1.3 Global Huntington’s Disease Treatment Market by Application
1.3.1 Overview: Global Huntington’s Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Huntington’s Disease Treatment Market Size & Forecast
1.5 Global Huntington’s Disease Treatment Market Size and Forecast by Region
1.5.1 Global Huntington’s Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Huntington’s Disease Treatment Market Size by Region, (2016-2021)
1.5.3 North America Huntington’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Huntington’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Huntington’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Huntington’s Disease Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Huntington’s Disease Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Huntington’s Disease Treatment Market Drivers
1.6.2 Huntington’s Disease Treatment Market Restraints
1.6.3 Huntington’s Disease Treatment Trends Analysis
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health Huntington’s Disease Treatment Product and Solutions
2.1.4 Bausch Health Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bausch Health Recent Developments and Future Plans
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
2.2.4 Teva Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.3 Wave Life Sciences
2.3.1 Wave Life Sciences Details
2.3.2 Wave Life Sciences Major Business
2.3.3 Wave Life Sciences Huntington’s Disease Treatment Product and Solutions
2.3.4 Wave Life Sciences Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Wave Life Sciences Recent Developments and Future Plans
2.4 Ionis Pharmaceuticals/ Roche
2.4.1 Ionis Pharmaceuticals/ Roche Details
2.4.2 Ionis Pharmaceuticals/ Roche Major Business
2.4.3 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product and Solutions
2.4.4 Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ionis Pharmaceuticals/ Roche Recent Developments and Future Plans
2.5 Raptor Pharmaceuticals
2.5.1 Raptor Pharmaceuticals Details
2.5.2 Raptor Pharmaceuticals Major Business
2.5.3 Raptor Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
2.5.4 Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Raptor Pharmaceuticals Recent Developments and Future Plans
2.6 Prana Biotechnology
2.6.1 Prana Biotechnology Details
2.6.2 Prana Biotechnology Major Business
2.6.3 Prana Biotechnology Huntington’s Disease Treatment Product and Solutions
2.6.4 Prana Biotechnology Huntington’s Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Prana Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Huntington’s Disease Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Huntington’s Disease Treatment Players Market Share
3.2.2 Top 10 Huntington’s Disease Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Huntington’s Disease Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Huntington’s Disease Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Huntington’s Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Huntington’s Disease Treatment Revenue Market Share by Application (2016-2021)
5.2 Huntington’s Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Huntington’s Disease Treatment Revenue by Type (2016-2026)
6.2 North America Huntington’s Disease Treatment Revenue by Application (2016-2026)
6.3 North America Huntington’s Disease Treatment Market Size by Country
6.3.1 North America Huntington’s Disease Treatment Revenue by Country (2016-2026)
6.3.2 United States Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Huntington’s Disease Treatment Revenue by Type (2016-2026)
7.2 Europe Huntington’s Disease Treatment Revenue by Application (2016-2026)
7.3 Europe Huntington’s Disease Treatment Market Size by Country
7.3.1 Europe Huntington’s Disease Treatment Revenue by Country (2016-2026)
7.3.2 Germany Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.3 France Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Huntington’s Disease Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Huntington’s Disease Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Huntington’s Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Huntington’s Disease Treatment Revenue by Region (2016-2026)
8.3.2 China Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.5 India Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Huntington’s Disease Treatment Revenue by Type (2016-2026)
9.2 South America Huntington’s Disease Treatment Revenue by Application (2016-2026)
9.3 South America Huntington’s Disease Treatment Market Size by Country
9.3.1 South America Huntington’s Disease Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Huntington’s Disease Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Huntington’s Disease Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Huntington’s Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Huntington’s Disease Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Huntington’s Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Huntington’s Disease Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Huntington’s Disease Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Huntington’s Disease Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Huntington’s Disease Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Huntington’s Disease Treatment Revenue Market Share by Region (2021-2026)
Table 6. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 7. Bausch Health Major Business
Table 8. Bausch Health Huntington’s Disease Treatment Product and Solutions
Table 9. Bausch Health Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Teva Pharmaceuticals Major Business
Table 12. Teva Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
Table 13. Teva Pharmaceuticals Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Wave Life Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Wave Life Sciences Major Business
Table 16. Wave Life Sciences Huntington’s Disease Treatment Product and Solutions
Table 17. Wave Life Sciences Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ionis Pharmaceuticals/ Roche Corporate Information, Head Office, and Major Competitors
Table 19. Ionis Pharmaceuticals/ Roche Major Business
Table 20. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Product and Solutions
Table 21. Ionis Pharmaceuticals/ Roche Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Raptor Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Raptor Pharmaceuticals Major Business
Table 24. Raptor Pharmaceuticals Huntington’s Disease Treatment Product and Solutions
Table 25. Raptor Pharmaceuticals Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Prana Biotechnology Corporate Information, Head Office, and Major Competitors
Table 27. Prana Biotechnology Major Business
Table 28. Prana Biotechnology Huntington’s Disease Treatment Product and Solutions
Table 29. Prana Biotechnology Huntington’s Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Huntington’s Disease Treatment Revenue (USD Million) by Players (2019-2021)
Table 31. Global Huntington’s Disease Treatment Revenue Share by Players (2019-2021)
Table 32. Breakdown of Huntington’s Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Huntington’s Disease Treatment Players Head Office, Products and Services Provided
Table 34. Huntington’s Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 35. Huntington’s Disease Treatment New Entrants and Expansion Plans
Table 36. Global Huntington’s Disease Treatment Revenue (USD Million) by Type (2016-2021)
Table 37. Global Huntington’s Disease Treatment Revenue Share by Type (2016-2021)
Table 38. Global Huntington’s Disease Treatment Revenue Forecast by Type (2021-2026)
Table 39. Global Huntington’s Disease Treatment Revenue by Application (2016-2021)
Table 40. Global Huntington’s Disease Treatment Revenue Forecast by Application (2021-2026)
Table 41. North America Huntington’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Huntington’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Huntington’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Huntington’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Huntington’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Huntington’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Huntington’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Huntington’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Huntington’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Huntington’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Huntington’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Huntington’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Huntington’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Huntington’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Huntington’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Huntington’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Huntington’s Disease Treatment Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Huntington’s Disease Treatment Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Huntington’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Huntington’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Huntington’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Huntington’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Huntington’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Huntington’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Huntington’s Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Huntington’s Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Huntington’s Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Huntington’s Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Huntington’s Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Huntington’s Disease Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Huntington’s Disease Treatment Picture
Figure 2. Global Huntington’s Disease Treatment Revenue Market Share by Type in 2020
Figure 3. Symptomatic Therapy
Figure 4. Disease-Modifying Therapy
Figure 5. Huntington’s Disease Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Global Huntington’s Disease Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Huntington’s Disease Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Huntington’s Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 11. Global Huntington’s Disease Treatment Revenue Market Share by Region in 2020
Figure 12. North America Huntington’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Huntington’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Huntington’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Huntington’s Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Huntington’s Disease Treatment Market Drivers
Figure 17. Huntington’s Disease Treatment Market Restraints
Figure 18. Huntington’s Disease Treatment Market Trends
Figure 19. Bausch Health Recent Developments and Future Plans
Figure 20. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 21. Wave Life Sciences Recent Developments and Future Plans
Figure 22. Ionis Pharmaceuticals/ Roche Recent Developments and Future Plans
Figure 23. Raptor Pharmaceuticals Recent Developments and Future Plans
Figure 24. Prana Biotechnology Recent Developments and Future Plans
Figure 26. Global Huntington’s Disease Treatment Revenue Share by Players in 2020
Figure 27. Huntington’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Huntington’s Disease Treatment Revenue Market Share in 2020
Figure 29. Global Top 10 Players Huntington’s Disease Treatment Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Huntington’s Disease Treatment Revenue Share by Type in 2020
Figure 32. Global Huntington’s Disease Treatment Market Share Forecast by Type (2021-2026)
Figure 33. Global Huntington’s Disease Treatment Revenue Share by Application in 2020
Figure 34. Global Huntington’s Disease Treatment Market Share Forecast by Application (2021-2026)
Figure 35. North America Huntington’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 36. North America Huntington’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 37. North America Huntington’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 38. United States Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Huntington’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 42. Europe Huntington’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 43. Europe Huntington’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 44. Germany Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Huntington’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Huntington’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Huntington’s Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 52. China Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Huntington’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 59. South America Huntington’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 60. South America Huntington’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Huntington’s Disease Treatment Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Huntington’s Disease Treatment Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Huntington’s Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Huntington’s Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source
世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…- 世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
- 世界の髄膜炎菌性疾患治療市場 2021：企業別、地域別、種類・用途別 The Meningococcal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のフォンウィルブランド病治療市場 2021：企業別、地域別、種類・用途別 The Von Willebrand Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のニューカッスル病治療市場規模・現状・予測（2021年-2027年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…